Live
What will the FDA's decision be on Vamikibart by Genentech on or before July 31, 2027?
Starts:Oct 28, 2026, 9:00 PMEnds:Aug 1, 2027, 3:59 AM
GMIKSHLMTNVGPLYPMU
Total volume
$6
Largest spread
—
Outcomes
2
Platforms
1
Markets
1
Markets
Every market on this event, moneyline first. Select one to compare it across platforms in the side panel.
| Outcome | Best | Gemini | Kalshi | Limitless | Novig | Polymarket | Polymarket US |
|---|---|---|---|---|---|---|---|
Yes No liquidity | — | — | No liquidity66.0% | — | — | — | — |
No No liquidity | — | — | No liquidity34.0% | — | — | — | — |
YesNo liquidity
KalshiNo liquidity66.0%
NoNo liquidity
KalshiNo liquidity34.0%
Description from Kalshi. A cross-platform summary is generated once this event is matched across platforms.
If the FDA's decision on Vamikibart by Genentech on or before July 31, 2027 is a full approval or an accelerated approval, the market resolves to Yes. This market will resolve to No if the FDA's decision is a denial (CRL issued), a withdrawal by the sponsor, or a conditional approval — or if no decision is issued.
Discussion (0)
Log in to join the discussion.
No comments yet — start the discussion.